Determination of Mirtazapine and Desmethyl Mirtazapine in Human Plasma by a New Validated HPLC Ultraviolet Method with a Simple and Reliable Extraction Method: Application to Therapeutic Drug Monitoring Study by 62 Real Patient Plasma

AuthorEmrah Duralen
AuthorNilay Sedes Baskaken
AuthorHatice Özcanen
AuthorYağmur Kıren
AuthorBora Başkaken
AuthorHalil Sinan Süzenen
Issued Date2020-01-31en
AbstractDetermination of mirtazapine (MRP) during psychopharmacotherapy in biological fluids is essential to achieve successful therapy, to avoid toxicity related to drug interactions, genetic variability, and poor compliance. A new, rapid, and sensitive high-performance liquid chromatography method has been developed in human plasma for the determination of MRP and N-desmethylmirtazapine (NDM) that is an active metabolite.en
DOIhttps://doi.org/10.22037/ijpr.2019.14599.12519en
KeywordMirtazapineen
KeywordN-desmethylmirtazapineen
KeywordPlasmaen
KeywordHPLC-UVen
KeywordTherapeutic drug monitoringen
KeywordValidationen
PublisherBrieflandsen
TitleDetermination of Mirtazapine and Desmethyl Mirtazapine in Human Plasma by a New Validated HPLC Ultraviolet Method with a Simple and Reliable Extraction Method: Application to Therapeutic Drug Monitoring Study by 62 Real Patient Plasmaen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-19-18.pdf
Size:
467.62 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF